Suchergebnis | Hamburg Open Science

Facetten

30 Einträge gefunden

A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy
2020 - Forschungsinformationssystem des UKE
High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy
2017 - Forschungsinformationssystem des UKE
Salvage Radical Prostatectomy for recurrent Prostate Cancer: Verification of EAU guideline criteria
2015 - Forschungsinformationssystem des UKE
Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?
2013 - Forschungsinformationssystem des UKE
The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers.
2012 - Forschungsinformationssystem des UKE
Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomy
2012 - Forschungsinformationssystem des UKE
Full functional-length urethral sphincter preservation during radical prostatectomy.
2011 - Forschungsinformationssystem des UKE
High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.
2011 - Forschungsinformationssystem des UKE
Current Technique of Open Intrafascial Nerve-Sparing Retropubic Prostatectomy.
2009 - Forschungsinformationssystem des UKE
Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.
2009 - Forschungsinformationssystem des UKE
Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.
2009 - Forschungsinformationssystem des UKE
Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.
2008 - Forschungsinformationssystem des UKE
Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.
2008 - Forschungsinformationssystem des UKE
Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.
2007 - Forschungsinformationssystem des UKE
Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.
2007 - Forschungsinformationssystem des UKE
Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.
2007 - Forschungsinformationssystem des UKE
Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.
2006 - Forschungsinformationssystem des UKE
Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy.
2006 - Forschungsinformationssystem des UKE
Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.
2006 - Forschungsinformationssystem des UKE

Aktive Facetten

Facetten

Zugriff

Einrichtung

Medientyp

Karte

Erscheinungsjahr

Autor/in

Sprache

A pre-specified model based on four kallikrein markers in blood improves predictions of adverse pathology and biochemical recurrence after radical prostatectomy

High Chance of Late Recovery of Urinary and Erectile Function Beyond 12 Months After Radical Prostatectomy

Salvage Radical Prostatectomy for recurrent Prostate Cancer: Verification of EAU guideline criteria

Open and robot-assisted radical retropubic prostatectomy in men receiving ongoing low-dose aspirin medication: revisiting an old paradigm?

The impact of the number of cores on tissue microarray studies investigating prostate cancer biomarkers.

Assessment of rates of lymph nodes and lymph node metastases in periprostatic fat pads in a consecutive cohort treated with retropubic radical prostatectomy

Full functional-length urethral sphincter preservation during radical prostatectomy.

High level PSMA expression is associated with early PSA recurrence in surgically treated prostate cancer.

Current Technique of Open Intrafascial Nerve-Sparing Retropubic Prostatectomy.

Importance of baseline potency rate assessment of men diagnosed with clinically localized prostate cancer prior to radical prostatectomy.

Long-term data on the survival of patients with prostate cancer treated with radical prostatectomy in the prostate-specific antigen era.

Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.

Percent free prostate-specific antigen (PSA) is an accurate predictor of prostate cancer risk in men with serum PSA 2.5 ng/mL and lower.

Assessment of pathological prostate cancer characteristics in men with favorable biopsy features on predominantly sextant biopsy.

Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer.

Free PSA isoforms and intact and cleaved forms of urokinase plasminogen activator receptor in serum improve selection of patients for prostate cancer biopsy.

Comparison of free and total forms of serum human kallikrein 2 and prostate-specific antigen for prediction of locally advanced and recurrent prostate cancer.

Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.

Comparative assessment of the 1992 and 2002 pathologic T3 substages for the prediction of biochemical recurrence after radical prostatectomy.

Development and internal validation of a nomogram predicting the probability of prostate cancer Gleason sum upgrading between biopsy and radical prostatectomy pathology.